Clinical Trial Update: The Effectiveness of Idazoxan in Treating TRD [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Idazoxan for treatment-resistant depression has been withdrawn by the sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Idazoxan (Idazoxan)

Snippet

Sponsor: Sheba Medical Center | Conditions: Major Depressive Disorder | Phase 3 | Status: WITHDRAWN